Evidence Documents – Cipla Drug Trial

LIST OF DOCUMENTS RELIED UPON BY THE COMPLAINANT

S.No.Description of documentPage Nos.
1(Civil Suit) – Order by the Executive Committee of Maharashtra Medical Council.61-67
2(Civil Suit) – Order by Maharashtra State Consumer Disputes Redressal Commission (Consumer Court).68-87
3Bone marrow biopsy report.88
4Death Certificate issued by Jupiter Hospital.89
5Death Summary issued by Jupiter Hospital.90
6Email from treating doctor, Dr.Mihirgiri Goswami dated 01/08/2014.91-93
7Schedule ‘M’ of Drugs and Cosmetics Rules in respect of product complaints with drug manufacturers.94-95
8Complaint to Cipla Limited dated 16.08.2014.96-98
9Email by Complainant dated 26/08/2014 to Dr.Akhtar of Cipla Drugs Safety for follow up on his complaint.99-100
10Reply from Cipla Drugs Safety – Email dated 27/08/2014.101-104
11Product information of drug Rokfos sent with above reply.105-119
12Email by Complainant to Cipla Drugs Safety dated 07/07/2016 for follow up on his complaint and reply received from Cipla Drug Safety.120-125
13Email by Complainant to Mr.Umang Vohra, Managing Director & Global CEO, Cipla Ltd. dated 18/04/2017 and reply received from Drug Safety Division.126-130
14Letter from Complainant dated 18/04/2017 sent to Mr.Umang Vohra, Managing Director & Global CEO, Cipla Ltd. as a follow up to his Email of same date.131-136
15Letter dated 16/04/2018 received by the Complainant from Director, Food & Drugs Administration, Government of Goa regarding reply by Cipla to Show Cause notice.137
16Explanation dated 26.03.2018 by Cipla Head Global Pharmacovigilance in Show Cause by FDA Goa Director.138-150
17Letter from Complainant to FDA Goa Director dated 21.04.2018 on false explanation by Cipla.151-152
18Letter from Complainant to Cipla Head Global Pharmacovigilance, Dr.Avinash Kakade dated 01.05.2018 on his false explanation to FDA Goa Director.153-154
19Letter from Complainant to Cipla Board of Directors dated 09.05.2018 demanding unconditional apology for false remarks on his wife’s health (paralysis) prior to Rokfos being administered to her.155-157
20Reply dated 18.05.2018 by Cipla Authorised Representative to my demand for apology and threatening legal proceedings.158-159
21Complainant’s reply dated 28.05.2018 to the above letter.160-170
22Reply dated 31.05.2018 by Cipla Authorised Representative to Complainant’s letter dated 28.05.2018.171-176
23Physician’s fitness for surgery to the patient in in-patient records of Maruti Nursing Home.177
24Reply to RTI Query of the Complainant from FDA Goa that Cipla had not reported the serious ADRs and that no drugs were recalled.178
25Reply to RTI Query of the Complainant from IPC (PVPI) that they have no record of the adverse event of Rokfos IV Infusion manufactured by Cipla.179
26Letter from DCG(I) for investigation – alleged nexus between M/s Cipla Ltd. and M/s Maruti Nursing Home, Mulund, Mumbai in sale of sub-standard drugs Rokfos i.v.180-181
27Complainant’s reply dated 06.06.2018 to letter dated 31.05.2018 from Cipla’s Authorised Representative.182-211
28Reply by Cipla Authorised Representative dated 26.06.2018 to Complainant’s letter dated 06.06.2018 stating that they will comply with the directions of the authorities as and when received.212-213
29Complainant’s letter dated 04.03.2019 to Mr.Yusuf Hamied, Cipla Chairman for malpractices and criminal offences at Cipla.214-215
30Complainant’s letter dated 04.03.2019 to Mr.Yusuf Hamied for an Inspirational Science Program and ‘Yusuf Hamied Quotes’ vs ‘Reality at Cipla’.216-241
31US FDA Warning to Cipla Limited – Media report.242
32US FDA Detailed warning to Cipla – Violation of Good Manufacturing Practices at Goa plant.243-251
33Official reporting by Cipla of the serious ADRs of Rokfos to DCG(I), IPC (PVPI) and FDA Goa.252-254
34Media report on Cipla overcharging of Drugs – NPPA disclosure.255-256
35Complaint dated 28.04.2015 with FDA Maharashtra, Mumbai.257-261
36FDA Maharashtra, Mumbai, Zone 4 Assistant Commissioner’s letter to Complainant dated 28.01.2016 for seizure of drugs at Maruti Nursing Home – Illegal sale under Drugs & Cosmetics Act, 1940.262
37List of subsequent complaints, correspondence and deliberate false, evasive and misleading replies to Complainant’s RTI queries by FDA Maharashtra, Mumbai.263-267
38RTI Query & reply dated 16/10/2019 by PIO of FDA Maharashtra, Mumbai.268-269
39Complaint by Complainant dated 14th May 2018 to Joint Commissioner of FDA Maharashtra attaching letter to Cipla Management for unconditional apology for defamatory remarks on his wife’s health and action against Cipla, Maruti Nursing Home and FDA officials.270-277
40Proof of corruption at FDA Maharashtra, Mumbai – Media report.278
41Status of case at 15th Court, Mazgaon, Mumbai filed by Drug Inspector of FDA Maharashtra under FDA Commissioner against Maruti Nursing Home – No action since 2015.279-280
42Maharashtra tops in sub-standard drugs – Statement by MOS Health on December 13, 2019 in Parliament.281
43Joint Investigation Report – Letter dated 11/02/2020 to the Complainant from Department of Medical Education & Drugs, Mantralaya, Mumbai enclosing Joint Investigation Report conducted by CDSCO (WZ), FDA Maharashtra & Professor & Head of Department, Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai (Expert) in death of Complainant’s wife, Smt. Kamini Barkur.282-292
44Photograph of carton of drug Rokfos.293
45Purchase invoice No.00788 dated 25/04/2014 for drug Rokfos received from AMI Agency.294
46Maruti Nursing Home bill for Rokfos sold to Complainant @Rs.3,500/-.295
47Indications of use of Zoledronic acid296
48CRP (quantitative) test not performed.297
49ADR evidence in in-patient record – ‘Post Zobone Arthralgia’.298
50Side effects of Rokfos (Zoledronic Acid) from Google search.299
51Side effects of Zobone  (Zoledronic Acid) from Google search.300
52In-patient noting of ‘Rash’ by physician, Dr.Dolare.301
53Subject Expert Committee (SEC) at CDSCO on ADRs of Zoledronic acid.302-303
54Information received from Secretary cum Scientific Director, National Coordination Centre, Pharmacovigilance Programme of India, IPC, Ghaziabad.304
55Letter from FDA Goa Director to DCG(I) dated 15/05/2018 for necessary action at his end.305
56Letter to Cipla Limited by FDA Goa Director dated 03/21/2019.306
57Letter to Complainant by FDA Goa Director dated 15/05/2019.307
58Letter dated 23/05/2019 to Complainant by ADC(I) that matter is under active consideration.308
59Letter by Complainant to FDA Goa Director dated 12/06/2019.309-314
60Complaint to Chief Minister of Goa against FDA Goa Director and Inspection Officers dated 21st December 2020.315-319
61RTI dated 09th February 2021 to Office of Chief Minister of Goa.320-339
62Police complaint with Mulund Police dated 10.04.2017.340-341
63List of subsequent complaints, correspondence and deliberate, false, evasive and misleading replies to Complainant’s RTI queries by D.H.S, Dean of Sir J.J.Group of Hospitals.342-344
64Police Complaint sent to Directorate of Health Services, Public Health Department transferred via Navghar police to Dean of Sir J.J.Group of Hospitals. Letter dated 24.07.2018.345
65Reply to RTI Query dated 02.08.2018 from D.H.S. that matter pertains to Navghar police.346
66Appointment of Expert Committee by the Dean of Sir J.J.Group of Hospitals.347
67Letter from Inspector Vikas Bhujbal of Navghar Police that information will be given to the Complainant after receipt of details from the Dean of Sir J.J.Group of Hospitals.348
68Reply to RTI Query of Complainant by PIO of Sir J.J.Group of Hospitals regarding expert committee report. That the report cannot be given to the complainant as it is confidential. That they have no authority to give details to Police Station for framing charges against the accused and register an FIR.349
69Reply from Mulund Police to RTI query of Complainant that the status of his police complaint is pending for expert opinion.350
70Online complaint to the Office of Lokayukta of Maharashtra. Attached was Order of Consumer Court.351-353
71Attached to complaint with the Lokayukta was Cipla sub-standard drug Rokfos Expose.354-368
72Attached to complaint with the Lokayukta was Questionnaire to Cipla.369-371
73Corruption in FDA (Proof).372-380
74Letter to the Hon’ble Lokayukta by the Complainant dated 26th November detailing how the Dean and Expert Committee lied to the Lokayukta.381-398
75Letter to the Dean of Sir J.J.Group of Hospitals enclosing the above letter to the Lokayukta.399-401
76Letter dated 19/12/2020 addressed jointly to 1)Director, Health Services, Public Health Department, Govt. of Maharashtra. 2) Director, Directorate of Medical Education and Research, Govt. of Maharashtra. 3) Dean, Sir J.J. Group of Hospitals. Cc: The Hon’ble Lokayukta of Maharashtra for hearing on 30.12.2020.402-409
77Letter to the Lokayukta dated 01.01.2021 that no justice can be delivered by the Dean of Sir J.J.Group of Hospitals and the Expert Committee.410-427
78Email to the Hon’ble Lokayukta dated 03/01/2021 for destruction and tampering of evidence by the Dean and Expert Committee Chairman, Dr.Abdul Hannan.428-432
79Email to the hon’ble Lokayuta/Upa-Lokayukta dated 15/01/2021 giving full evidence for action; now that both the Law enforcement authorities against whom they were supposed to follow up for action are themselves the accused for colluding with criminal offenders.433-450
80RTI to Office of Lokayukta dated 03.02.2021 regarding information from Dean of Sir J.J.Group of Hospitals.451-462
81 RTI to Office of Lokayukta dated 04.02.2021 regarding action taken against FDA Maharashtra officials.463-466
82Complaint dated 01.01.2021 with Commissioner of Police, Mumbai regarding destruction of evidence and tampering of evidence by Dean and Expert Committee at Sir J.J.Group of Hospitals. Book on ‘CIPLA DRUG TRIAL’ was sent.Copy of Complaint to Cabinet Secretary dated 27.01.2021 was sent to Police Commissioner.Copy of Order by Maharashtra Medical Council was sent to Police Commissioner.Copy of Status of case at Mazgaon Court filed by FDA Drug Inspector was sent to the Police Commissioner.467-468
83RTI to Joint Commissioner of Police dated 13th February 2021.469-500
84Complaint to WHO Representative to India, Dr.Henk Bekedam dated 9th July 2019.501-506
85Complaint to WHO Director General Dr.Tedros Adhanom dated 8th October 2019.507
86Complaint to WHO Chief Scientist, Dr.Soumya Swaminathan dated 9th March 2020. Book on CIPLA DRUG TRIAL was sent to her.508-509
87Cabinet Secretariat Order/Advice to Health Secretary for action in Cipla Drug Trial case.  510-512
88PMO Replies to RTI by Complainant – On complaints vide PMOPG portal.513-514
89Prime Minister on New Rules for doctors and Pharma companies – media report.515
90Prime Minister on Consumer Protection – media report.516
91CDSCO proposed amendments to Drugs and Cosmetics Act, 1940 – media report.517
92Standard Medical Textbooks on Aplastic Anaemia.518-548
93Transcripts of meeting held on 22nd August 2014 arranged by treating doctor and owner of Maruti Nursing Home with relatives of the deceased.549-673
94Complaint to Commissioner of Police dated 07/04/2022.674-678
95Full-fledged Lokayukta Justice V.M.Kanade – Letter dated 27/10/2021 after 1st hearing on 20/10/2021.679-701
96Letter to Lokayukta dated 27/10/2021 regarding Memorandum of Parties – Departments who colluded with Criminal offenders.702-716
97Letter to Lokayukta dated 27/10/2021 regarding complainant’s response to “Fake Joint Investigation”.717-742
98Letter dated 12th January 2022 to the Lokayukta & Governor after shocking 2nd hearing on 06/01/2022.743-761
99Appointment of Expert Committee by Dean of Sir J.J.Group of Hospitals on 29th August 2018.762
100Letter dated 24th November 2019 from Navghar, Mulund Police Station that status of police complaint is pending for expert opinion.763
101Reply to RTI Query of Complainant from FDA Maharashtra that Rokfos is manufactured by Cipla which comes under the jurisdiction of Goa.764-765
102FDA Goa Director’s warning to Cipla dated 18/01/2018.766-767
103Letter dated 26.07.2018 from DCG(I) Dr.S.Eswara Reddy to National Coordination Centre, Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission.768-769
104Letter dated 10.09.2018 from ADC(I) Shri Somnath Basu to the National Coordination Centre, Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission.770-771
105Letter dated 30.11.2018 from DDC(I) Shri A.K.Pradhan to Secretary-cum-Scientific Director of Indian Pharmacopoeia Commission.772-773
106Letter dated 05.12.2018 from ADC(I) Shri Somnath Basu to Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission.774
107Letter dated 21/03/2019 by FDA Goa Director to Cipla that no action is taken upon an assurance that such lapses are not reported in the future.775-776
108E-mail dated 26th March 2019 to Drugs Controller General (India) regarding my feedback on resolution of my grievance.777-778
109Reply to RTI query from CDSCO – Subject Expert Committee had opined that the reported adverse reactions like arthralgia, myalgia, bone paint, etc are known side effects of the said drug.779
110Letter from ADC (I) Shri Somnath Basu dated 20/04/2021 related to ADRs of Zoledronic acid. (All drug controllers have been caught in Fake Investigation).780-781
111Vide letter dated 17/01/2022, DCG(I) wrote to FDA Goa Director to examine the matter and take appropriate action under intimation to DCG(I) office.782-783
112Media Report of Joint Drugs Controller, Dr.S.Eswara Reddy being arrested in bribery case ET June 22, 2022.784-785
113Health Matters: Media Report that India must Regulate Drug Regulatory Body First –  Bribery Controversy Blessing in Disguise News18 – Himani Chandna.786-789
114PM Modi’s speeches on Doctor-Pharma Nexus & Consumer Protection being a must for New India – Media report – Oct 26, 2017.790-791
115CDSCO – Pharma companies could face Penalty – Media Report – 23.11.2017.792
116New Drugs Bill – Prescription for Disaster – Dinesh Thakur & Prashant Reddy T write in The Indian Express 08.08.2022793-795
117Fake Joint Investigation – Explained to Lokayukta of Maharashtra – 27th October 2021.796-821
118Lokayukta Solo Order W/O minutes of Hearing dated 22.02.2022 sent vide Office of Lokayukta letter dated 17.03.2022.822-827
119Governor of Maharashtra – Reply by Complainant on Lokayukta’s Fake Order.828-845
120Lokpal Disposal Order (filled with lies) dated 24th August 2021 sent on 31st August 2021.846-850
121Reply by Complainant to Lokpal Disposal Order.851-885
122Lokpal Gimmick to wriggle out after CBI complaint. Letter dated 11th August 2022.886-888
123Complainant’s reply to Lokpal’s gimmick.889-900
124Letter to Governor, Shri Bhagat Singh Koshyari with Support letters from Family & Friends dated 29th July 2028. [Full details of Foul Play by Lokayukta has been sent to the Governor in multiple letters].901-906
125Complaint to Minister for Consumer Affairs – 01st July 2021.907-950
126Complaint to CBI19th July 2022 – Full facts – Sequence of events – Dr.Eswara Reddy arrest. Complaint to Union Health Minister dated 06th August 2022 – Suspension of Dr.P.B.N.Prasad, Shri Somnath Basu, Dr.V.G.Somani & Shri Rajesh Bhushan – Notices to Cipla Directors – Notices to Stakeholders – Suspension of Cipla Licence: Copy of Complaint to NHRC 06th August 2022. Copy of complaint to Hon’ble President 06th August 2022. Criminal offences by Cipla Limited. Copy of complaint to Hon’ble President – New Drugs Bill – 12th August 2022. Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD. Copy of Complaint to Union Health Minister dated 30th August 2022 – Lokpal tampering of evidence – Suspension of Dr.P.B.N.Prasad, Shri Somnath Basu, Dr.V.G.Somani & Shri Rajesh Bhushan – Notices to Cipla Directors – Notices to Stakeholders – Suspension of Cipla.951-972
127CBI – Copy of Complaint to Health Minister on Lokpal tampering + NHRC Order Inlimine.973-974
128Complaint before President of India28th July 2022 including sequence of events (Succinct Summary) – Also sought appointment. Email dated 02nd August 2022 to Hon’ble President – Being INHUMAN – Full Episode with Evidence documents.Complaint to Union Health Minister dated 06th August 2022 – Suspension of Dr.P.B.N.Prasad, Shri Somnath Basu, Dr.V.G.Somani & Shri Rajesh Bhushan – Notices to Cipla Directors – Notices to Stakeholders – Suspension of Cipla Licence.Copy of Complaint to NHRC – 06th August 2022.Complaint to Central Bureau of Investigation – 06th August 2022.Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD.975-996
129Complaint to Hon’ble President – CDSCO officers should be halted – Law makers will write obituary of 140 crore citizens – 12th August 2022.997-1009
130Complaint to Union Health Minister dated 06th August 2022 – Suspension of Dr.P.B.N.Prasad, Shri Somnath Basu, Dr.V.G.Somani & Shri Rajesh Bhushan – Notices to Cipla Directors – Notices to Stakeholders – Suspension of Cipla Licence – Copy of this letter was addressed to: CBINHRCHon’ble PresidentCipla LimitedEmail dated 02nd August 2022 to Hon’ble President – Being INHUMAN – Full Episode with Evidence documents.Copy of letter addressed to Hon’ble President on New   Drugs Bill – 12th August 2022.Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD.Complaint to Health Minister on “Fake Joint Investigation Report to absolve Cipla. Hard copy sent on 30th August 2022. File name ?? Email dated 02nd September 2022 to Addl P.S. to Health Minister. Hard copy sent on 03rd Sept 2022. File name MOHFW EMAIL – ANIL KUMAR RADADIYA1010-1014
131Complaint to Union Health Minister dated 30th August 2022 – Lokpal tampering of evidence – Suspension of Dr.P.B.N.Prasad, Shri Somnath Basu, Dr.V.G.Somani & Shri Rajesh Bhushan – Notices to Cipla Directors – Notices to Stakeholders – Suspension of Cipla. Copy sent to CBI.http://pgportal.gov.in/status PMOPG/D/2022/0188024 PMOPG/D/2022/0220340 (12th August addressed to PM with copy of complaint to President). Shri S. Gopalakrishnan (Additional Secretary) Organisation name Health & Family Welfare Contact Address Room No. 252, A Wing, Nirman Bhawan New Delhi Email Address ash-mohfw@nic.in Contact Number 01123061066  1015-1021
132Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD. Email dated 02nd August 2022 to Hon’ble President – Being INHUMAN – Full Episode with Evidence documents.1022-1037
133Complaint to SFIO (Serious Fraud Investigation Office) enclosing; Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD.1038
134Complaint to National Human Rights Commission (NHRC)  04th July 2022 including Memorandum of Parties & Index of documents. Complaint to Union Health Minister dated 06th August 2022 – Suspension of Dr.P.B.N.Prasad, Shri Somnath Basu, Dr.V.G.Somani & Shri Rajesh Bhushan – Notices to Cipla Directors – Notices to Stakeholders – Suspension of Cipla Licence.Copy of complaint to CBI – 06th August 2022.Copy of complaint to Hon’ble President – 06th August 2022.Email dated 02nd August 2022 to Hon’ble President – Being INHUMAN – Full Episode with Evidence documents.Copy of complaint to Hon’ble President – 12th August 2022 – CDSCO officers to be halted.Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD.1039-1042
135Complaint to National Human Rights Commission (NHRC) after disposal of my complaint In limine – Email dated 24.08.2022. Hard copy sent on 28.08.2022.1043-1051
136Supreme Court of India – Writ against Respondents – File Name PDF SCI Evidence documents upto Page 673 Foul Play by Justice R.K.Agrawal. Foul Play by Lokpal of India. Foul Play by Lokayukta of Maharashtra. Cipla Drug Trial. Mercy Petition Not PIL 2 CJIs & 6 Judges FILE – SUPREME COURT – CABINET SECRETARY -27.01.2021 The Supreme Court had taken Suo Moto cognizance of my Appeal jointly to the Hon’ble President, Hon’ble Prime Minister and the Hon’ble Chief Justice of India. “Your Grievance/Communication has been successfully registered as Diary No.6819/SCI/PIL(E)2020. Later, on October 5, 2020 messaged me “Your Grievance/Communication registered against Diary No.6819/2020, has been lodged/filed on 29-09-2020 as contents of complaint are not covered under PIL guidelines.   I am sending you copy of my grievance addressed before the Cabinet Secretary (India) as well as my book on death of my wife in ‘CIPLA DRUG TRIAL’. FILE – CABINET SECRETARY – COMPLAINT DATED 26.01.2021 FILE – SUPREME COURT – CABINET SECRETARY 01.02.2021 16068/SCI/PIL(E)/2021 – LETTER OF 27.01.2021   37554/PIL/2021 01.06.2021 56976/SCI/PIL/2021 05.04.2021 6 JUDGES 67719/SCI/PIL/2021 29.07.2021 CONSUMER AFFAIRS 76434/SCI/PIL/2021 07.09.2021 LETTER DT 21.08.2021 R.K.AGRAWAL 88762/SCI/PIL/2021 05.10.2021 LETTER DT 28.09.2021 LOKPAL 10459/SCI/PIL/2022 LETTER DT 12.01.2022 LOKAYUKTA 18960/SCI/PIL/2022 LETTER DT 21.03.2022 MERCY PETITION Grievance Redressal Status : 37554/PIL/2021 01.06.2021 Date of Action : 25-03-2022 Status Information : NO ACTION TAKEN SINCE CONTENTS OF COMPLAINT ARE NOT COVERED UNDER PIL GUIDELINES.   56976/SCI/PIL/2021 05.04.2021 BEFORE 6 JUDGES Date of Action : 22-02-2022 Status Information : NO ACTION TAKEN SINCE CONTENTS OF COMPLAINT ARE NOT COVERED UNDER PIL GUIDELINES.   67719/SCI/PIL/2021 29.07.2021 CONSUMER AFFAIRS Date of Action : 19-05-2022 Status Information : NO ACTION TAKEN SINCE CONTENTS OF COMPLAINT ARE NOT COVERED UNDER PIL GUIDELINES.   76434/SCI/PIL/2021 07.09.2021 LETTER DT 21.08.2021 R.K.AGRAWAL Date of Action : 19-05-2022 Status Information : NO ACTION TAKEN SINCE CONTENTS OF COMPLAINT ARE NOT COVERED UNDER PIL GUIDELINES.   88762/SCI/PIL/2021 05.10.2021 LETTER DT 28.09.2021 LOKPAL Status Information : UNDER PROCESS   10459/SCI/PIL/2022 LETTER DT 12.01.2022 LOKAYUKTA Status Information : UNDER PROCESS   18960/SCI/PIL/2022 LETTER DT 21.03.2022 MERCY PETITION Status Information : UNDER PROCESS Copy of complaint to Hon’ble President – 12th August 2022 – CDSCO officers to be halted.Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD. 
138Ex-President Shri Ramnath Kovind – From 2018 To 2022 
139BEING INHUMAN IN NEW INDIA – Email dated 02nd August 2022 to Hon’ble President – Being INHUMAN – Full Episode with Evidence documents. 
140Complaint to Cipla Limited – Company Secretary Complaint to Union Health Minister dated 06th August 2022 – Suspension of Dr.P.B.N.Prasad, Shri Somnath Basu, Dr.V.G.Somani & Shri Rajesh Bhushan – Notices to Cipla Directors – Notices to Stakeholders – Suspension of Cipla Licence.Copy of complaint to Hon’ble President – 12th August 2022 – CDSCO officers to be halted.Complaint to Under Secretary (Drugs Regulation) – 15th August 2022 – New Drugs Bill is a FRAUD.Email – Complaint to National Human Rights Commission (NHRC) after disposal of case In limine – Email dated 24.08.2022. Hard copy sent on 28.08.2022. 
 Cipla Drug Trial – Succinct Summary – Sequence of Events22 pages
 CIPLA DRUG TRIAL – Open & Shut homicide explained with Evidence documents.112 pages
 Cipla Drug Trial – Memorandum of Parties2 pages
 Cipla Drug Trial – Index of documents (Evidence)9 pages
141DGHS – Complaint against Dr.S.Eswara Reddy dated 18.07.20231052-1077
142Written submissions by Dr.Mihirgiri Goswami that the drug did not suit the complainants wife1078
143Complaint before Lokayukta dated 31.10.20191079-1082
144Reply to Lokayukta Illegal disposal Order to close Police Complaint1083-1091
145Conclusion by Professor of Medical Anthropology1092